Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Fungi (Basel) ; 7(1)2021 Jan 13.
Artículo en Inglés | MEDLINE | ID: mdl-33451062

RESUMEN

BACKGROUND: Paracoccidioidomycosis (PCM) is a chronic disease that causes sequelae and requires prolonged treatment; therefore, new therapeutic approaches are necessary. In view of this, three peptides from Paracoccidioides brasiliensis 14-3-3 protein were selected based on its immunogenicity and therapeutic potential. METHODS: The in vitro antifungal activity and cytotoxicity of the 14-3-3 peptides were evaluated. The influence of the peptides in immunological and survival aspects was evaluated in vivo, using Galleria mellonella and the expression of antimicrobial peptide genes in Caenorhabditis elegans. RESULTS: None of the peptides were toxic to HaCaT (skin keratinocyte), MRC-5 (lung fibroblast), and A549 (pneumocyte) cell lines, and only P1 exhibited antifungal activity against Paracoccidioides spp. The peptides could induce an immune response in G. mellonella. Moreover, the peptides caused a delay in the death of Paracoccidioides spp. infected larvae. Regarding C. elegans, the three peptides were able to increase the expression of the antimicrobial peptides. These peptides had essential effects on different aspects of Paracoccidioides spp. infection showing potential for a therapeutic vaccine. Future studies using mammalian methods are necessary to validate our findings.

2.
Microb Pathog ; 125: 116-121, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30205192

RESUMEN

Candida auris emerged as a pathogen resistant to multiple antifungal and has been associated with nosocomial outbreaks with high transmission capacity between hospitalized individuals. C. auris was first described in 2009, after being isolated from the external ear canal discharge of a patient in Japan. The difficulty in identification, incorrect use of antifungal drugs, and treatment failure are causes of high mortality. Since then, C. auris has been increasingly reported from East Asia to North America, with substantial fatalities and misidentification. This review aims at describing the epidemiology, virulence, risk factors, resistance, and therapeutic options in C. auris infections.


Asunto(s)
Candida/aislamiento & purificación , Candidiasis/epidemiología , Candidiasis/microbiología , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Antifúngicos/farmacología , Antifúngicos/uso terapéutico , Asia/epidemiología , Candida/efectos de los fármacos , Candida/patogenicidad , Candidiasis/tratamiento farmacológico , Candidiasis/patología , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/patología , Farmacorresistencia Fúngica , Humanos , América del Norte/epidemiología , Factores de Riesgo , Análisis de Supervivencia , Virulencia
3.
Future Microbiol ; 13: 359-367, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29464962

RESUMEN

AIM: This work aimed to produce a membrane based on fluconazole-loaded natural rubber latex (NRL), and study their interaction, drug release and antifungal susceptibility against Candida albicans. MATERIALS & METHODS: Fluconazole-loaded NRL membrane was obtained by casting method. RESULTS: The Fourier Transform Infrared Spectroscopy showed no modifications either in NRL or fluconazole after the incorporation. Mechanical test presented low Young's modulus and high strain, indicating the membranes have sufficient elasticity for biomedical application. The bio-membrane was able to release the drug and inhibit the growth of C. albicans as demonstrated by disk diffusion and macrodilution assays. CONCLUSION: The biomembrane was able to release fluconazole and inhibit the growth of C. albicans, representing a promising biomaterial for skin application.


Asunto(s)
Antifúngicos/química , Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Materiales Biocompatibles Revestidos/química , Materiales Biocompatibles Revestidos/farmacología , Fluconazol/química , Látex/química , Liberación de Fármacos , Fluconazol/farmacología , Pruebas de Sensibilidad Microbiana , Resistencia a la Tracción
4.
Future Microbiol ; 12: 1123-1134, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28876122

RESUMEN

AIM: This work aimed to evaluate the activity of 3'-hydroxychalcone against Cryptococcus gattii in planktonic and biofilm forms and their toxicity using alternative animal models. MATERIALS & METHODS: Minimum inhibitory concentration and minimum fungicide concentration were determined. Biofilm formation and the susceptibility tests were performed by the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-5-[carbonyl(phenylamino)]-2H-tetrazolium hydroxide assay. Toxicity and efficacy were checked in Danio rerio and Galleria mellonella models. RESULTS: The compound 3'-hydroxychalcone showed fungicidal activity against C. gattii in both planktonic and biofilm forms. The toxicity in zebrafish embryos revealed a low lethal concentration. In G. mellonella, the compound did not show antifungal activity and larvae toxicity. CONCLUSION: Because of the activity of 3'-hydroxychalcone against C. gattii in vitro, molecular modifications should be made to improve efficacy and to reduce toxicity in vivo. [Formula: see text].


Asunto(s)
Antifúngicos/farmacología , Cryptococcus gattii/efectos de los fármacos , Modelos Animales de Enfermedad , Animales , Antifúngicos/química , Biopelículas/efectos de los fármacos , Criptococosis/microbiología , Cryptococcus gattii/citología , Lepidópteros/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Microscopía Electrónica de Rastreo , Pez Cebra
5.
Int J Antimicrob Agents ; 48(5): 504-511, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27742203

RESUMEN

Cryptococcosis is an opportunistic fungal infection responsible for high morbidity and mortality in immunocompromised patients. Combination of antifungal substances is a promising way to increase the percentage of successful treatment. Pedalitin (PED) is a natural substance obtained from Pterogyne nitens. The aim of this study was to verify the efficacy of PED alone and in combination with amphotericin B (AmB) in vitro and in vivo against Cryptococcus spp. In the in vitro assay, minimum inhibitory concentrations (MICs) of 0.125 mg/L for AmB and 3.9 mg/L for PED were found when the substances were tested alone, whilst in the combination treatment the active concentration of both decreased, with MICs of 0.03 mg/L for AmB and 1 mg/L for PED. In the survival assay, fungal burden study and histopathological assays it was possible to study the efficacy of the substances alone and in combination. The efficacy of combination therapy was considered better than monotherapy as evaluated in a Galleria mellonella model and a murine model. Thus, the combination of PED and AmB is an interesting alternative for anticryptococcal fungal treatment. Moreover, a correlation was observed between the invertebrate and murine models for this antifungal treatment combination.


Asunto(s)
Anfotericina B/farmacología , Antifúngicos/farmacología , Cryptococcus neoformans/efectos de los fármacos , Sinergismo Farmacológico , Flavonas/farmacología , Anfotericina B/administración & dosificación , Animales , Antifúngicos/administración & dosificación , Recuento de Colonia Microbiana , Criptococosis/tratamiento farmacológico , Criptococosis/microbiología , Modelos Animales de Enfermedad , Flavonas/administración & dosificación , Lepidópteros , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Análisis de Supervivencia , Resultado del Tratamiento
6.
Future Microbiol ; 11: 1299-1313, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27662506

RESUMEN

AIM: This study aims to understand which Candida orthopsilosis protein aids fungus adaptation upon its switching from planktonic growth to biofilm. MATERIALS & METHODS: Ion mobility separation within mass spectrometry analysis combination were used. RESULTS: Proteins mapped for different biosynthetic pathways showed that selective ribosome autophagy might occur in biofilms. Glucose, used as a carbon source in the glycolytic flux, changed to glycogen and trehalose. CONCLUSION: Candida orthopsilosis expresses proteins that combine a variety of mechanisms to provide yeasts with the means to adjust the catalytic properties of enzymes. Adjustment of the enzymes helps modulate the biosynthesis/degradation rates of the available nutrients, in order to control and coordinate the metabolic pathways that enable cells to express an adequate response to nutrient availability.


Asunto(s)
Biopelículas/crecimiento & desarrollo , Candida/metabolismo , Candida/fisiología , Metaboloma/fisiología , Plancton/crecimiento & desarrollo , Aminoácidos/biosíntesis , Aminoácidos/genética , Candida/genética , Candida/crecimiento & desarrollo , Carbono/metabolismo , Ciclo del Ácido Cítrico , Proteínas Fúngicas/biosíntesis , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Proteínas Fúngicas/fisiología , Regulación Fúngica de la Expresión Génica/genética , Regulación Fúngica de la Expresión Génica/fisiología , Ontología de Genes , Glucosa/metabolismo , Glucógeno/metabolismo , Glucólisis , Análisis de Flujos Metabólicos , Redes y Vías Metabólicas/genética , Redes y Vías Metabólicas/fisiología , Metaboloma/genética , Familia de Multigenes , Plancton/metabolismo , Plancton/fisiología , Proteoma/genética , Proteoma/metabolismo , Proteoma/fisiología , Trehalosa/metabolismo
7.
Antimicrob Agents Chemother ; 57(5): 2417-21, 2013 05.
Artículo en Inglés | MEDLINE | ID: mdl-23478969

RESUMEN

Biofilms have been observed in the fluid pathways of hemodialysis machines. The impacts of four biocides used for the disinfection of hemodialysis systems were tested against Candida parapsilosis sensu stricto and Candida orthopsilosis biofilms generated by isolates obtained from a hydraulic circuit that were collected in a hemodialysis unit. Acetic acid was shown to be the most effective agent against Candida biofilms. Strategies for effective disinfection procedures used for hemodialysis systems should also seek to kill and inhibit biofilms.


Asunto(s)
Ácido Acético/farmacología , Antifúngicos/farmacología , Biopelículas/efectos de los fármacos , Candida/efectos de los fármacos , Desinfectantes/farmacología , Riñones Artificiales/microbiología , Biopelículas/crecimiento & desarrollo , Candida/crecimiento & desarrollo , Unidades de Hemodiálisis en Hospital , Humanos , Peróxido de Hidrógeno/farmacología , Ácido Peracético/farmacología , Hipoclorito de Sodio/farmacología
8.
Yeast ; 25(2): 141-54, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18098122

RESUMEN

The dimorphic fungus Paracoccidioides brasiliensis is the causative agent of the most frequent systemic mycosis in Latin America. In humans, infection starts by inhalation of fungal propagules, which reach the pulmonary epithelium and differentiate into the yeast parasitic phase. Here we describe the characterization of a Dfg5p (defective for filamentous growth) homologue of P. brasiliensis, a predictable cell wall protein, first identified in Saccharomyces cerevisiae. The protein, the cDNA and genomic sequences were analysed. The cloned cDNA was expressed in Escherichia coli and the purified rPbDfg5p was used to obtain polyclonal antibodies. Immunoelectron microscopy and biochemical studies demonstrated the presence of PbDfg5p in the fungal cell wall. Enzymatic treatments identified PbDfg5p as a beta-glucan linked protein that undergoes N-glycosylation. The rPbDfg5p bound to extracellular matrix components, indicating that those interactions could be important for initial steps leading to P. brasiliensis attachment and colonization of host tissues.


Asunto(s)
Pared Celular/metabolismo , Proteínas Fúngicas/metabolismo , Paracoccidioides/crecimiento & desarrollo , Paracoccidioides/metabolismo , Ácido 2-Metil-4-clorofenoxiacético , Secuencia de Aminoácidos , Secuencia de Bases , ADN Complementario/genética , ADN de Hongos/genética , Dicamba , Combinación de Medicamentos , Fluorenos , Proteínas Fúngicas/genética , Regulación Fúngica de la Expresión Génica , Genes Fúngicos , Genoma Fúngico , Humanos , Datos de Secuencia Molecular , Paracoccidioides/genética , Paracoccidioides/ultraestructura , Paracoccidioidomicosis/sangre , Paracoccidioidomicosis/inmunología , Unión Proteica
9.
Microbes Infect ; 8(12-13): 2686-97, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16962356

RESUMEN

Paracoccidioides brasiliensis causes infection by the host inhalation of airborne propagules of the mycelia phase of the fungus. These particles reach the lungs, and disseminate to virtually all organs. Here we describe the identification of differentially expressed genes in studies of host-fungus interaction. We analyzed two cDNA populations of P. brasiliensis, one obtained from infected animals and the other an admixture of fungus and human blood thus mimicking the hematologic events of the fungal dissemination. Our analysis identified transcripts differentially expressed. Genes related to iron acquisition, melanin synthesis and cell defense were specially upregulated in the mouse model of infection. The upregulated transcripts of yeast cells during incubation with human blood were those predominantly related to cell wall remodeling/synthesis. The expression pattern of genes was independently confirmed in host conditions, revealing their potential role in the infection process. This work can facilitate functional studies of novel regulated genes that may be important for the survival and growth strategies of P. brasiliensis in humans.


Asunto(s)
Regulación Fúngica de la Expresión Génica , Paracoccidioides/genética , Paracoccidioides/patogenicidad , Paracoccidioidomicosis/microbiología , Adaptación Fisiológica/genética , Animales , Northern Blotting , ADN Complementario , Etiquetas de Secuencia Expresada , Fungemia/microbiología , Perfilación de la Expresión Génica , Biblioteca de Genes , Genes Fúngicos , Humanos , Ratones , Ratones Endogámicos BALB C , Hibridación de Ácido Nucleico , Paracoccidioides/fisiología , ARN de Hongos/biosíntesis , ARN de Hongos/genética , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transcripción Genética , Virulencia/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA